United States · FDA National Drug Code directory
Galantamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-459_a5420811-7ce9-4ea6-8d93-6422f016b0d8
- Product NDC
- 65862-459
- Form
- TABLET, FILM COATED
- Composition / generic term
- Galantamine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110329
- Source listing expiry
- 20261231
Source-listed ingredients
- GALANTAMINE HYDROBROMIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (65862-459-60) · 65862-459-60
- 7000 TABLET, FILM COATED in 1 BOTTLE (65862-459-71) · 65862-459-71
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-459-99) · 65862-459-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →